Optiver Holding
CRL icon

Optiver Holding’s Charles River Laboratories CRL Stock Holding History

Optiver Holding’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-103
Closed -$20.5K – 2405
2025
Q4 		$20.5K Buy
+103
New +$18.7K ﹤0.01% 1022
2025
Q1 		– Sell
-201
Closed -$37.1K – 1377
2024
Q4 		$37.1K Buy
+201
New +$38.7K ﹤0.01% 630
2024
Q3 		– Sell
-97
Closed -$20K – 970
2024
Q2 		$20K Buy
+97
New +$22K ﹤0.01% 640

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Optiver Holding's CRL Position: Q1 2026 in Review

Optiver Holding sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 103 shares — an estimated $20.5K sold.

Optiver Holding first reported a position in CRL in Q2 2024 and held it in 3 quarters. The position peaked at $37.1K in Q4 2024. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Optiver Holding reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Optiver Holding sold 103 Charles River Laboratories shares in Q1 2026, an estimated $20.5K.
  • Optiver Holding first reported a position in Charles River Laboratories in Q2 2024 and held it in 3 quarters.
  • Optiver Holding's Charles River Laboratories position peaked at $37.1K in Q4 2024.
  • 560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.